Following print's best year since 2011, it's time to rewrite those journal-advertising obituaries. Medical-surgical print journal spending in 2015 was up 8.4% to $372 million.
Here are the brands and companies that advertised the most on professional ads in 2015.
New analysis says Paxil is not safe or effective for teens; some FDA reviewers voted against Addyi approval over side effects; HHS partners with AstraZeneca on antibiotic development
Elsevier is taking a hard-line posture against several different universities, asking them to take down scholarly research.
The Heath, Labor and Welfare ministry says a publisher passed off advertorials as articles.
Doctors shared their information preferences with CMI/Compas, revealing ways marketers can better pace their communications to max out channels.
Studies show that printed pieces still hold sway in the industry.
Starting next year, the BMJ will not publish academic papers on drugs or devices unless the relevant anonymized patient-level data are made available for third-party study.
The American Medical Association has wooed New England Journal of Medicine publisher Tom Easley to Chicago, where he will preside over the society's publications, soon to be rolled up into the JAMA brand.
A study found fraud rampant in retracted journal articles -- and publishers less than transparent about why articles were pulled
Privately owned Quadrant HealthCom acquired International Medical News Group (IMNG) from Elsevier, creating a new medical-publishing juggernaut.
Statistics show medical professionals are migrating toward iPads. Now, one medical journal publisher says, advertisers have followed.
In an effort to shore up their reputations, pharma and professional publishers have come together to craft an accountability plan.
Journals are a curious media form in that they provide fodder for debate on medical topics, but not a forum in which to hold one. Enter JAMA's new Viewpoint feature.
An email from Harvard University's Faculty Advisory Council over the cost of professional journals has touched off the latest round in the Universities vs Publishers sparring match.
Medical journal coverage of the question of physician-industry relationships is "unbalanced" and may be skewing public policy towards ever-more restrictive safeguards against industry influence.
Publicis Groupe is expanding its footprint in China, having acquired the healthcare communications agency U-Link Solutions Co. Ltd.
The Medical Advertising Hall of Fame announced its 2012 inductees: Medical Economics' Charles Daly, Sudler & Hennessey creative great Ernest Smith and LLNS co-founder Al Nickel.
Researchers analyzing the prevalence of ghostwriting in leading medical journals over more than a decade saw a decline but found inappropriate authorship remained all too common.
Four out of five ads analyzed in a study of physician-directed pharmaceutical advertising would definitely not pass FDA muster, or might have trouble doing so, said researchers. Their findings may have implications for the FDA, DDMAC and the "Bad Ad" program.
The American Association for Cancer Research will launch a new journal -- Cancer Discovery -- in April 2011. The peer-reviewed journal will focus on research spanning cancer science and medicine, including news, commentaries, and "Research Watch" summaries of important journal articles.
Quadrant HealthCom united two titles - The Female Patient and OBG Management - under an alliance providing advertisers with a "ping-pong" opportunity for campaigns.
Custom media provider Sequence Personal, and CMI, have partnered to create SequenceDoc, a portal for physicians offering tailored medical content served up as an on-demand print journal, or as a digital download.
Thieme Publishers will distribute UK-based Manson Publishing titles in the Americas and India, a portfolio that includes close to 100 medical and veterinary titles.
The New England Journal of Medicine launched a new website on July 24, including an archive of past issues dating back to 1812. Over 150,000 articles are now available for digital searching and perusal.
Sage, an international publisher of medical journals, books and electronic media, is shifting all of its 560-plus titles onto a new platform hosted by Stanford University Libraries' HighWire Press.
Medical society journals must ban ghostwritten articles and cannot place ads for drugs next to editorial content discussing those products or their makers under a sweeping ethics code signed by several major medical societies.
First Lady Michelle Obama's recent announcement of a campaign to end childhood obesity was not lost on medical publisher Mary Ann Liebert, Inc., which will roll out a new journal, Childhood Obesity, in June 2010.
An alliance with the nation's largest soft drink maker to sponsor advice on sugar-free alternatives has spurred criticism of the American Academy of Family Physicians (AAFP).
Researchers submitting manuscripts to many medical journals will have to fill out a more probing disclosure form aimed at exposing potential conflicts of interest.
- Biogen ends Tecfidera DTC campaign, citing prescriptions
- As immuno-oncology therapies evolve, so will the marketing
- GSK Consumer Healthcare to prioritize digital after agency review
- Five things for pharma marketers to know: Thursday, July 21, 2016
- Five things for pharma marketers to know: Tuesday, July 26, 2016
- Merck educates doctors about biosimilars, long before it will sell one in the U.S.
- 4 trends with the potential to change behavior in the patient journey
- 2016 Pharma Report: All the data in one place
- What do physicians think about biosimilars?
- Novartis considers new sales model for experimental cancer therapy
- Sponsored Podcast: No Patient Left Behind: Connecting Rare Disease Patients to Orphan Drug Manufacturers
- W2O names Gillespie chief strategy officer of medtech practice
- Five things for pharma marketers to know: Wednesday, July 27, 2016
- DigitasLBi's Carlos Ricque on Why Simple Ads Are the Hardest to Make
- Healthcare marketers: Don't forget about the baby boomers